Initiate
- Company typePrivate
- Founded2019
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingServices
Initiate firmographics
Firmographics- Name
- Initiate
- Legal name
- Initiate Consultancy Limited
- Website
- https://initiateconsultancy.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Initiate industry classification
Industry- Product category
- Market Access Consulting
- NAICS
- Marketing Consulting Services (541613), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Health Economics & Outcomes Research (HEOR) (HLAIAKAB)
- akta.pro secondary industries
- Payer & HTA Engagement (Reimbursement/Submissions) (HLAIAKAD), Real-World Evidence (RWE) & HEOR for Development (HLAIALAI), Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)
Keywords
Where Initiate is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices4 records
Markets served
Initiate business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Consulting Services: Initiate provides professional consultancy services for market access, HEOR, HTA submissions, health economics modelling, value communication, pricing strategy, and training. Pricing is project-based and customized based on client needs and project scope.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based custom pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Initiate product offering
Product offeringCore offering
Initiate is a market access and Health Economics Outcomes Research (HEOR) consultancy serving pharmaceutical, medical device, and diagnostic companies. It delivers HTA submissions, health economic modelling, evidence synthesis, pricing and reimbursement strategy, value communication, and training services across 50+ countries, with a particular specialization in rare and complex diseases.
Product overview
Initiate Consultancy is a market access and Health Economics Outcomes Research (HEOR) consultancy that provides a comprehensive suite of services across the pharmaceutical, medical device, and diagnostic sectors. The company operates as a single unified consultancy offering seven core service lines: Health Technology Assessment, Health Economics & Evidence Synthesis, Value Communication & Launch Preparation, Pricing & Reimbursement, Payer & Clinical Insights, Asset Evaluation & Market Opportunity, and Training & Learning Support. Additionally, the company produces the Initiation Podcast as an educational and thought leadership resource. Initiate serves global pharmaceutical clients and affiliates, with particular expertise in rare and complex diseases, and maintains a 98% HTA submission success rate with over 130 global submissions delivered.
Differentiator
Problem solved
Functional benefit
Products and services
- Health Technology Assessment Comprehensive HTA services including strategy development, submission writing, health economic modelling, statistical analysis, systematic literature reviews, indirect treatment comparisons, and post-submission support across global markets. Designed for pharmaceutical, biotech, and medical device sponsors requiring reimbursement approvals.
- Health Economics & Evidence Synthesis Health economics and evidence synthesis services including cost-effectiveness modelling, health policy modelling, budget impact modelling, systematic literature reviews, meta-analyses, real-world evidence generation, and statistical analysis. Targeted at life sciences sponsors building HEOR evidence packages.
- Value Communication & Launch Preparation Value communication and launch preparation services including value dossier development, payer value propositions, early HEOR value strategy, launch sequencing, price strategy development, access strategy, and tender strategy services. Built for manufacturers preparing for product launch across global markets.
- Pricing & Reimbursement Pricing and reimbursement services including HTA submissions and strategy, cost minimisation modelling, pricing research, international reference pricing analysis, therapeutic product profile research, and forecast development. Aimed at manufacturers seeking market-specific pricing and reimbursement outcomes.
- Payer & Clinical Insights Payer and clinical insights services including modified Delphi research, 1:1 interviews, online surveys, advisory boards, economic model validation, group pricing studies, and landscape analyses. Used by manufacturers to gather payer and clinician input to inform market access strategy.
- Asset Evaluation & Market Opportunity Asset evaluation services including in-licensing evaluation, price evaluation, forecasting, reimbursement strategy development and testing, and therapeutic product profile research. Supports business development and portfolio decision-making at pharma and biotech firms.
- Training & Learning Support Training and learning support including bespoke health economic training workshops, HTA submission workshops, lunch and learn sessions, mock committee meetings, and expert panel participation. Delivered to internal client teams building market access capability.
Quantifiable outcome
- 98% HTA submission success rate
- +4 more outcomes
Companies that use Initiate
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Initiate technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Initiate partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Initiate competitors and assessment
Company assessmentDirect peers
- Evidera (an IQVIA company): Evidera is the largest dedicated HEOR and market access consultancy globally, offering HTA submissions, health economic modelling, and value communication to pharma and MedTech — the same core service mix as Initiate but at much greater scale and with deeper geographic reach.
- Avalere Health: Avalere provides market access, HEOR, and policy advisory services to pharmaceutical, biotech, and medical device clients, with strong US payer engagement and growing international practice. Direct competitor in HTA submission strategy and value communication.
- Xcenda (Cencora): Xcenda is a market access and HEOR consultancy within Cencora, focused on pharmaceutical pricing, reimbursement, and HTA submissions in the US and Europe. Overlaps with Initiate on payer engagement, value communication, and global market access strategy.
Broad incumbents
- Parexel International: Parexel is a global CRO with a dedicated market access, HEOR, and pricing practice serving top pharma and biotech. Broader scope than Initiate (full clinical development plus commercial), but directly competes on HEOR and HTA engagements.
- ICON plc: ICON is a global CRO with significant HEOR and market access capabilities inherited from PRA Health Sciences. Competes for the same multi-market HTA and value communication engagements as Initiate, with substantially larger delivery capacity.
- Charles River Associates (Life Sciences practice): CRA's Life Sciences practice provides HEOR, market access, pricing, and commercial strategy consulting to global pharma and biotech. Direct overlap with Initiate on health economics modelling and value demonstration, embedded within a broader strategy consulting firm.
Emerging players
- BresMed Health Solutions: BresMed is a UK-based HEOR and market access consultancy offering health economic modelling, evidence synthesis, and HTA submission support to pharma and MedTech — closely comparable in scale and specialism to Initiate, with a similar rare-disease orientation.
- Valid Insight: Valid Insight is a UK-based market access and HEOR consultancy providing value communication, HTA submissions, and pricing strategy to pharmaceutical and MedTech clients. Direct niche competitor to Initiate, particularly on EU HTA submissions and value dossier development.
- Source HEOR: Source HEOR is a boutique HEOR consultancy providing evidence synthesis, health economic modelling, and HTA support globally. Overlaps with Initiate on rare disease and complex evidence challenges, though with a smaller delivery footprint.
- PHMR Ltd: PHMR is a UK-based market access and health economics consultancy providing HTA submissions, evidence reviews, and pricing strategy to pharma and biotech. Closely comparable scale and service profile to Initiate, with overlapping European client base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Initiate social profiles
Digital presenceInitiate compliance and trust
Trust signalCompliance1 record
Initiate financial estimates
Financial estimateRevenue estimate
Valuation estimate
Initiate leadership team
Management profileNumber of profiles
Profiles8 records
Initiate funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Initiate M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Initiate
What does Initiate do?
Initiate is a market access and Health Economics Outcomes Research (HEOR) consultancy serving pharmaceutical, medical device, and diagnostic companies. It delivers HTA submissions, health economic modelling, evidence synthesis, pricing and reimbursement strategy, value communication, and training services across 50+ countries, with a particular specialization in rare and complex diseases.
Is Initiate a public or private company?
Initiate is a private company. It is classified as private equity controlled and is currently operating.
When was Initiate founded?
Initiate was founded in 2019. It employs 1 to 10 people.
Where is Initiate based?
Initiate is headquartered in London, United Kingdom, in the Europe region.
How does Initiate make money?
One revenue line is on record: consulting Services.
Who are Initiate's main competitors?
Direct peers on record are Evidera (an IQVIA company), Avalere Health and Xcenda (Cencora). Broad incumbents are Parexel International, ICON plc and Charles River Associates (Life Sciences practice). Emerging players are BresMed Health Solutions, Valid Insight, Source HEOR and PHMR Ltd.
Does Initiate have an API?
No public API is recorded for Initiate.
What industry is Initiate in?
Initiate's product category is Market Access Consulting. Its primary akta.pro industry code is HLAIAKAB, Health Economics & Outcomes Research (HEOR), with a secondary code of HLAIAKAD, Payer & HTA Engagement (Reimbursement/Submissions). Its NAICS code is 541613 and its SIC code is 8742.